Article Text
Therapeutics/Prevention
Systematic review with meta analysis
Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes
Statistics from Altmetric.com
Footnotes
Twitter Follow Victor Montori at @vmontori
Disclaimer The KER UNIT of the Mayo Clinic conducts research into shared decision-making, including the design and testing of shared decision-making tools, including the one cited in the commentary which is freely available. The authors derive no income from the use of this free tool: http://shareddecisions.mayoclinic.org
Provenance and peer review Commissioned; internally peer reviewed.